维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Spiro TE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Laboratory assessmentof rivaroxaban: a review显示文摘	Samama MM Contant G Spiro TE	2013	Thromb J2013，11，1：	1
2	Low molecular weight heparin in prevention of restenosis after angiophsty:results of Enoxaparin Restenosis (ERA) trial 显示文摘	Faxon DP Spiro TE Minor S	1994	Circulation1994，90，：	1
3	Rivaroxaban for thromboprophylaxis in acutely ill medical patients显示文摘	Cohen AT Spiro TE Büller HR		0，，06：	1
4	Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients:MAGELLAN study protocol显示文摘	Cohen AT Spiro TE Büller HR		0，，04：	1
5	Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease显示文摘	Spiro TE Olsson CG	2001	Ann Intern Med2001，134，：	1
6	Prolonged enoxaparin thera- py to prevent venous thromboembolism after primary hip or knee re- plaeement Enoxaparin Clinical Trial Group 显示文摘	Comp PC Spiro TE Friedman RJ	2001	J Bone Joint Surg Am2001，83，3：	1
7	Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery显示文摘	Spiro TE Johnson GJ Christie MJ	1994	Ann Intern Med1994，121，2：	1
8	Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease显示文摘	Spiro TE Olsson CG Enoxaparin Clinical Trial Group	2001	Ann Intern Med2001，134，：	1
9	Prolonged enoxaparin tderapy to prevent venous tdromboembolism after primary dip or knee replacement显示文摘	Comp PC Spiro TE Friedman RJ	2001	Enoxaparin Clinical Trial Group J Bone Joint、Surg (Am)2001，83，：	1
10	D-dimer as a predictor of venousthromboembolism in acutely ill,hospitalizedpatients:a subanalysis of the randomized controlledMAGELLAN trial显示文摘	COHEN AT SPIRO TE SPYROPOULOSAC	2014	J Thromb Haemost2014，12，4：	1
11	Prevention of venous thromboembolic disease following pri mary total knee arthroplasty显示文摘	Fitzgerald RH Jr Spiro TE Trowbridge AA	2001	J Bone Joint Surg(Am)2001，83，：	1
12	Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparln for treat- ment of venous thromboembolic disease 显示文摘	Merli G Spiro TE Olsson CG	2001	Ann Intern Med2001，134，3：	1
13	D-dimer as a predictor of venous thromboembolism in acutely ill, hospi- talized patients:a subanalysis of the randomized controlled MAGELLAN trial显示文摘	Cohen AT Spiro TE Spyropoulos AC	2014	J Thromb Haemost2014，12，4：	1
14	Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease显示文摘	Merli G Spiro TE Olsson CG	2001	Ann Intern Med2001，134，3：	1
15	Eficacy and safety ofenox- aparin to prevent deep venous thrombosis after hip replacementsurgery 显示文摘	Spiro TE Johnson G J Christie M J	1994	Ann Intern Med1994，121，2：	1
16	Prolonged enoxapa- rin therapy to prevent venous thromboembolism after prima- ry hip or knee replacement Enoxaparin Clinical Trial Group 显示文摘	Comp PC Spiro TE Friedman R J	2001	J Bone Joint Surg Am2001，83，3：	1
17	D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients:a subanalysis of the randomized controlled MAGELLAN trial显示文摘	Cohen AT Spiro TE Spyropoulos AC	2014	J Thromb Haemost2014，12，4：	1
18	Prevention of venous tdromboembolic disease following primary total knee artdroplasty显示文摘	Fitzgerald Rd Jr Spiro TE Trowbridge AA	2001	J Bone Joint Surg(Am)2001，83，：	1
19	D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial显示文摘	Cohen AT Spiro TE Spyropoulos AC	2014	J Thromb Haemost2014，12，4：	1
20	Pre- vention of venous thromboembolic disease following primary total knee arthroplasty:A randomized,multi- center,open-label,parallel-group comparison of enoxa- parin and warfarin显示文摘	Fitzgerald RH Spiro TE Trowbridge AA	2001	J Bone Joint Surg Am2001，83，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示